Cancer World Newsletter - New paradigms to explain metastasis

New knowledge about the process of metastasis is calling into question treatment paradigms that focus purely on preventing cell division. In this e-grandround, Elizabeth Comen, part of the Memorial Sloan-Kettering team led by Larry Norton that has been leading much of this ground-breaking work, gives an overview of developments in our understanding of metastasis and looks at the potential of immunotherapy and other treatments aimed at manipulating the tumour microenvironment for inhibiting seeding of circulating cancer cells. What do you think? Is the search for new therapies still focused too heavily on finding ways to shrink tumours rather than inhibiting their capacity to spread?  You can read the article here. Press the comment button at the end and share your views.